Cyclerion Therapeutics, Inc.CYCNNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank3
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P3
Near historical low
vs 5Y Ago
-54.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -201.23% |
| Q2 2025 | 77.33% |
| Q1 2025 | -369.62% |
| Q4 2024 | 173.31% |
| Q3 2024 | 45.31% |
| Q2 2024 | 14.27% |
| Q1 2024 | 8.97% |
| Q4 2023 | -122.39% |
| Q3 2023 | 280.96% |
| Q2 2023 | 39.88% |
| Q1 2023 | 3.63% |
| Q4 2022 | 31.25% |
| Q3 2022 | 21.60% |
| Q2 2022 | -3.16% |
| Q1 2022 | -20.45% |
| Q4 2021 | 4.56% |
| Q3 2021 | 30.23% |
| Q2 2021 | -20.77% |
| Q1 2021 | 30.32% |
| Q4 2020 | -2.21% |
| Q3 2020 | 3.70% |
| Q2 2020 | 3.43% |
| Q1 2020 | 22.36% |
| Q4 2019 | 4.62% |
| Q3 2019 | 15.31% |
| Q2 2019 | 13.72% |
| Q1 2019 | -20.97% |
| Q4 2018 | -5.52% |
| Q3 2018 | 1.66% |
| Q2 2018 | -17.79% |
| Q1 2018 | 8.58% |
| Q4 2017 | -9.81% |
| Q3 2017 | 0.00% |